Last year, the U.S Food and Drug Administration (FDA) ordered DNA analysis service 23andMe to cease distribution of its test kits. Since then, the relationship between the two organizations has been an uneasy one. Over at New York Magazine, Lisa Miller explores 23andMe's complex history and the epistemological dispute at the heart of its conflict with the FDA. "It cares when a private company tells you that you have a gene that might kill you and sends you that tidbit in an email, which you can open alone, at night, without anyone near for comfort or consultation," Miller writes.